EyePoint Pharmaceuticals logo
EyePoint Pharmaceuticals EYPT
$ 11.62 -0.68%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

EyePoint Pharmaceuticals Cash Conversion Cycle 2011-2024 | EYPT

Annual Cash Conversion Cycle EyePoint Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
64.7 149 137 133 -75.3 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
149 -75.3 81.8

Quarterly Cash Conversion Cycle EyePoint Pharmaceuticals

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-420 - 34.3 -194 154 - 95.1 77.3 186 - 145 139 136 - 55 209 127 120 413 -122 -338 23.4 118 80 45 28.1 63.8 17.4 54.8 7.02 156 7.46 175 99.1 117 108 132 2.29 K 46.8 90.5 2.08 135 131 92 118 147 157 151 164 126 43.1 122 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
2.29 K -420 122